Decreased antibody-dependent cellular cytotoxicity in various types of leukaemia in man. 1981

M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska

Antibody-dependent cellular cytotoxicity (ADCC) by cells from peripheral blood was studied in patients with; chronic lymphocytic leukaemia (CLL), chronic granulocytic leukaemia (CGL), acute lymphoblastic leukaemia (ALL), acute non-lymphoid leukaemia (ANLL) and compared with that of healthy donors. The ADCC activity in all the types of leukaemia was on the average lower as compared with the control values, being especially low in both CLL and CGL. Further, it has also been shown that the ADCC activity of non-leukaemic blood cells in ANLL was lower as compared with control values. The latter observation indicates that, at least in ANLL, the reduced ADCC potential of peripheral blood cells is not due to dilution of effector cells by poorly- or non-active leukaemic cells.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
January 1983, Acta haematologica,
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
April 1988, Pediatric nephrology (Berlin, Germany),
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
December 1981, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
March 1977, Transplantation,
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
March 2001, Fertility and sterility,
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
October 1977, Developmental and comparative immunology,
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
January 1977, The Journal of allergy and clinical immunology,
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
September 2015, Leukemia,
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
January 2019, Frontiers in immunology,
M Jakóbisiak, and A Janowska-Wieczorek, and H Dobaczewska, and M Kańtoch, and M Marczak, and P Oblakowski, and W Lasek, and M Sosnowska
March 1975, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!